F
47
4
PBI
65
5
SJM
21
2
CMS
60
2
AIG
44
6
TRV
56
3
AN
54
4
CRM
65
6
HOG
33
4
EW
39
2
AVY
50
2
MRO
40
-15
GRMN
64
2
COF
58
3
CB
51
3
DOW
34
4
FRT
45
6
CMG
67
3
D
45
5
UNP
45
6
F
47
4
PBI
65
5
SJM
21
2
CMS
60
2
AIG
44
6
TRV
56
3
AN
54
4
CRM
65
6
HOG
33
4
EW
39
2
AVY
50
2
MRO
40
-15
GRMN
64
2
COF
58
3
CB
51
3
DOW
34
4
FRT
45
6
CMG
67
3
D
45
5
UNP
45
6
Financhill
Back

Adverum Biotechnologies Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
29

ADVM
Adverum Biotechnologies

Last Price:
6.05
Seasonality Move:
22.26%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Sell
29
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $5.75. The Score for ADVM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.75. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 24.35 Sell
Chaikin Money Flow: -683714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.87 - 8.23) Sell
Bollinger Bands (100): (6.75 - 7.99) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 47.09 Sell
Chaikin Money Flow: 727660 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.94 - 28.86) Sell
Bollinger Bands (100): (28.59 - 38.65) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.82 Sell
20-day SMA: 7.38 Sell
50-day SMA: 7.42 Sell
200-day SMA: 9.89 Sell
8-day EMA: 6.64 Sell
20-day EMA: 7.16 Sell
50-day EMA: 7.38 Sell
200-day EMA: 8.8 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.78 Sell
20-day SMA: 28.02 Sell
50-day SMA: 29.23 Sell
200-day SMA: 42.54 Sell
8-day EMA: 27.83 Sell
20-day EMA: 28.09 Sell
50-day EMA: 29.85 Sell
200-day EMA: 39.55 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):